ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

IL-2 Therapy Restores the Impaired Function of Regulatory T Cells Induced by Calcineurin Inhibitors in Liver Transplantation.

G. Whitehouse, E. Gray, S. Mastoridis, E. Kodela, A. Sanchez-Fueyo, M. Martinez-Llordella.

Liver Science Department, King's College London, London, United Kingdom.

Meeting: 2016 American Transplant Congress

Abstract number: 250

Keywords: Calcineurin, Interleukin-2 receptor, Liver transplantation, Tolerance

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Regulatory T Cells: Animal Models

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:54pm-3:06pm

Location: Room 309

Related Abstracts
  • The Function of CD8+TCR– Facilitating Cells and Regulatory T Cells Is Impaired in Flt3-Ligand Knockout Mice.
  • Rabbit Antithymocyte Globulin Induction Therapy Induces Donor-Specific HeliosnegFOXP3pos Regulatory T Cells in Kidney Transplant Patients

CD4+CD25+FOXP3+ regulatory T cells (Tregs) have an essential role in immune regulation and constitute a key target for cellular immunotherapies in transplantation. IL-2 is critical for Tregs function, and low-dose IL-2 therapy can exert beneficial effects in autoimmunity and GVHD. Calcineurin inhibitors (CNIs), which constitute the mainstay immunosuppression in liver transplantation, prevent rejection by inhibiting effector T cells, but also suppress Treg activity. CNIs also reduce the overall availability of IL-2. Our aims are to investigate the effects of CNIs on the Treg compartment by studying the homeostasis of the Treg subsets in human liver transplant recipients, and to elucidate if administration of low-dose IL-2 promotes the expansion and functional restoration of Tregs in the presence of CNIs both in humans and animal models.

We immunophenotyped PBMCs samples from 40 stable liver transplant recipients on CNI therapy >6 months post-transplant and 30 age-matched healthy controls. We assessed the effects of tacrolimus on Treg survival in vitro in a human whole blood culture system, and in vivo in a skin transplant mouse model (Bm12 into B6) in which allograft survival depends on tacrolimus treatment (5mg/kg/day).

Liver transplant recipients on CNIs displayed an increased cell turnover in the suppressive Treg subsets, with higher proliferation and apoptotic death than healthy controls. This was particularly striking in the activated Treg subset (CD4+CD45RA-Foxp3hi). Treg apoptosis correlated with soluble CD25 in serum. Tregs also exhibited reduced CD25 expression and lower IL-2 sensitivity. IL-2 therapy increased the number and function of Tregs in the presence of tacrolimus by upregulating the anti-apoptotic gene Bcl-2. Administration of tacrolimus to mice replicated the same phenotypic changes in Tregs. To confirm the beneficial effects of IL-2 in vivo we employed a CNI-dependent skin transplant model. Immunosuppression withdrawal was completed 4 weeks after transplantation. The allograft survival was significantly increased when IL-2 therapy (1ug rmIL-2+9ug mAbIL-2) was administered in combination with tacrolimus during the last week of treatment.

Our study provides a rationale for administering low-dose IL-2 to liver transplant recipients under CNI treatment to expand the pool of endogenous Tregs as a means to improve immunoregulation and potentially promote tolerance.

CITATION INFORMATION: Whitehouse G, Gray E, Mastoridis S, Kodela E, Sanchez-Fueyo A, Martinez-Llordella M. IL-2 Therapy Restores the Impaired Function of Regulatory T Cells Induced by Calcineurin Inhibitors in Liver Transplantation. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Whitehouse G, Gray E, Mastoridis S, Kodela E, Sanchez-Fueyo A, Martinez-Llordella M. IL-2 Therapy Restores the Impaired Function of Regulatory T Cells Induced by Calcineurin Inhibitors in Liver Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/il-2-therapy-restores-the-impaired-function-of-regulatory-t-cells-induced-by-calcineurin-inhibitors-in-liver-transplantation/. Accessed February 28, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.